Purpose: To evaluate the relationship between hypertension (HT) and other selected cardiovascular risk factors (age, gender, smoking, lipid profile) and the all cause mortality in patients with Alzheimer's Disease (AD). Methods: We evaluated 1083 patients with AD (390M, 693F, mean age 76,6±7,0 range 50-94 ys) referred to the Department of Neurology in Warsaw through years [2000][2001][2002][2003][2004][2005][2006].The AD was diagnosed on the basis of Mini Mental Scale (MMSE), NINCDS -ADRDA criteria for AD, DSM-IV criteria for AD and neurological and neuropsychological assessment. The level of cognitive impairment was assessed based on the MMSE score. All patients also underwent through evaluation including: assessment of cardiovascular risk factors, antihypertensive treatment and the results of laboratory tests.All cause mortality was estimated on the basis of data on deaths from the Central Statistical Office. Results: After the mean follow-up of 4,86 ys (range 0 -13 ys) all cause mortality was 66,1% (714 patients of mean age 77,3 ys (range 50-96ys)). The patients who have died were characterized by older age (77,3,1±6,73 vs 74,1±7,12ys, p<0,01) and more severe cognitive impairment (median MMSE score 17 vs 20, p <0,01) as compared to the patients who stayed alive during follow-up. There was no difference in the gender distribution between presented groups (frequency of female 62,5% vs 67,7%, p=0,09). Multivariate Cox model including age, gender, hypertension presence, dyslipidemia status, smoking status, level of education and the degree of cognitive impairment showed that male gender (Exp(B) = 0,796, ps<0,05), smoking (Exp(B) = 1,363, ps<0,05), older age (Exp(B) = 1,055, ps<0,0r), and lower score in MMSE ((Exp(B) = 0,950, ps<0,01) increased the risk of death in one year. Conclusions:, Our results show that in patients with AD, among analysed cardiovascular risk factors, only age, gender and smoking, but not the presence of hypertension and dyslipidemia status was associated with higher all cause mortality. Purpose: It is recognized that obstructive sleep apnea (OSA) plays an independent role in the pathogenesis of arterial hypertension. Left ventricular (LV) hypertrophy, especially concentric hypertrophy, is also well-known as an important prognostic predictor for cardiovascular events in patients with hypertension. We, therefore, assessed the relationship between LV hypertrophy and OSA severity among hypertensives using a new index, integrated area of desaturation (IAD), considering both duration and degree of hypoxia for analysis of polysomnography. Methods: This study comprised 227 hypertensive men under the age of 65 with OSA, who were free of cardiovascular diseases and had normal LV ejection fraction. They had overnight fully attended polysomnography with suspicion of sleep apnea in addition to echocardiography and laboratory check on the next morning. LV geometry was obtained in accordance with relationship between LV mass index and relative wall thickness ratio. Results: They had fairly good control of blood pressure (134.6±15.3/82.4±10.4 mmHg) and apnea-hypopnea index (AHI) of 44.9±27.1/hr. There was a weak but significant correlation between LV mass index (133.0±22.8 g/m 2 ) and IAD index (r=0.20, p<0.01). Patients with concentric hypertrophy had higher IAD index than those with normal geometry (132.2±167.8 vs. 91.7±116.5). A multivariate regression analysis showed that IAD, B-type natriuretic peptide and age -but not body mass index, blood pressure, low-density lipoprotein, HbA1c, hsCRP, plasma renin activity and plasma aldosterone concentration -were independent variables for detecting LV mass index (β=0.26, 0.24, 0.17, P<0.05, respectively). The IAD index was the only predictor among indices of sleep-disordered breathing such as AHI, oxygen desaturation index 3% and ratio of desaturation below 90%. Conclusions: Nocturnal intermittent hypoxia assessed by IAD may contribute to the development of LV hypertrophy in well-controlled hypertensive male patients.
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Heart-type fatty acid-binding protein is a novel prognostic marker in patients with essential hypertension Purpose: Heart-type fatty acid-binding protein (H-FABP), a sensitive marker of myocardial damage, is a useful diagnostic and prognositic marker in patients with cardiovascular disease, not only acute coronary syndrome but also chronic heart failure. We investigated whether H-FABP is a useful prognostic marker in patients with hypertension (HT), a major risk factor of acute coronary syndrome and heart failure. Methods: We measured serum levels of H-FABP in 192 patients with essential HT without prior cerebro-cardiovascular disease (CCVD) and renal failure (estimated glomerular filtration rate [eGFR] < 30ml/min/1.73m 2 ), and compared the prognostic value of H-FABP with clinical parameters including coronary risk factors, neurohumoral factors (plasma renin activity, plasma aldosterone, norepinephrine and B-type natriuretic peptide [BNP] concentrations) and echocardiographic findings. Results: Over a mean follow-up period of 55 months, 37 patients developed CCVD (15 heart failure, 3 acute coronary syndrome, 4 aortic dissection, 11 cerebral infarction, 2 cerebral hemorrhage, 1 transient ischemic attack and 1 arteriosclerosis obliterans). Kaplan-Meier analysis revealed that the freedom from CCVD rate was significantly lower in patients with H-FABP > 3.6 ng/ml (median value) than in those with H-FABP ≤ 3.6ng/ml (hazard ratio p=0.001). On a Cox multivariate analysis including 6 variables (male gender, eGFR < 60ml/min/1.73m 2 , diabetes, smoking and BNP and H-FABP > median value) that were significant predictors of CCVD by univariate analyses, H-FABP > 3.6 ng/ml (hazard ratio 2.37, p=0.03) and eGFR < 60ml/min/1.73m 2 (hazard ratio 2.21, p=0.03) were independent predictors of future CCVD. Conclusion: H-FABP is a novel and useful marker for the prediction of future CCVD beyond conventional risk factors in patients with essential HT.
P2374 | BEDSIDE
Self blood pressure monitoring improves awareness and attainment of target blood pressure goal: prospective observational study of 7,751 patients
